NCT05446805Recruiting
Depression and Driving
The Impact of Depression and Preclinical Alzheimer Disease on Driving Among Older Adults (Depression and Driving)
Source: ClinicalTrials.gov · Last updated 8 Jun 2026
Brief summary (registry, in English)
This project will assess how depression, preclinical AD, and antidepressants affect driving behavior in cognitively normal older adults (65 years).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 3 Jun 2022
- Start date
- 17 Jun 2021
- Primary completion date
- 17 Jun 2027
- Lead sponsor
- Washington University School of Medicine
- Diseases
- Alzheimer disease
- NCT number
- NCT05446805
What you commit to
- Study type: Observational
- Planned participants: 150
- From 17 Jun 2021 to the primary completion date, 17 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Less than 65 years of age
Other
- Not willing to complete blood draw and/or one other biomarker
- Does not drive a vehicle/ is no longer actively driving
Who the study is looking for
- Drive on average at least once per week
- Has a valid driver's license
- Willing to complete blood draw
- Willing to complete either lumbar puncture or PET imaging
- 65 years or older
- Speaks English
Age in the registry: 65 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Washington University School of Medicine Coordinator of this site? Confirm its status | St Louis | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.